Initial IHC evaluation of the rectal cancer specimen showed loss of PMS2 expression, with retention of MLH1, MSH2, and MSH6, suggesting a partial mismatch repair (MMR) deficiency. The gene discussed is MSH2; the disease is rectal cancer.